Human immunodeficiency virus type 1 (HIV-1) targets important cells of our immune system, making infected individuals more ...
HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...
A compound with the unpresuming designation of EBC-46 has made a splash in recent years for its cancer-fighting prowess. Now ...
A new chemical compound has been making a big impression in the fight against cancer in recent years. Now it seems EBC-46, otherwise known as tigilanol tiglate, may also have immense potential for ...
Researchers at the Max Planck Institute of Biophysics and Heidelberg University have observed largely intact HIV-1 capsids as ...
Curing HIV will be harder than curing cancer. Apart from a few 'miracle' cases, antiretrovirals only suppress HIV, they don't ...
SORSOGON CITY, Sorsogon (PIA) — The Department of Health – Bicol Center for Health Development (DOH-CHD) urges vulnerable ...
ACACIA Study Is Evaluating Two Long-Acting Broadly Neutralizing Antibodies Given at HIV Treatment InitiationLOS ANGELES, Jan.